Cagrilintide (CAGRI)

Cagrilintide is a long-acting amylin analogue studied in metabolic and appetite regulation research models. It is examined in amylin receptor signalling studies, appetite regulation research, energy balance pathway observation, metabolic hormone interaction studies, and glucose regulation research models, and is used strictly in controlled laboratory environments. Each vial contains 10mg of Cagrilintide as a lyophilised, freeze-dried powder in a sterile sealed vial, independently tested to a purity of 99% or higher by HPLC, with a certificate of analysis confirming purity for every batch. Designed and supplied for laboratory research use only.